| NCT ID | NCT03310905 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Transplant;Failure,Kidney |
| Study Type | INTERVENTIONAL |
| Enrollment | 5 participants |
| Start Date | 2018-05-01 |
| Primary Completion | 2028-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 5 participants in total. It began in 2018-05-01 with a primary completion date of 2028-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this protocol is to determine the safety and efficacy of abdominal wall transplantation as a treatment for the reconstruction of abdominal wall defects. Abdominal wall transplantation may be performed alone or in combination with another transplant.
Eligibility Criteria
Inclusion Criteria: * Candidates between 18-65 years old * Willingness and legal ability to give consent * Abdominal Wall in combination with another organ transplant: they must be eligible for the non-vascularized composite allograft organ transplant at Duke Exclusion Criteria: * Malignancy at evaluation or history of malignancy that precludes transplantation * Pregnancy: Women who are of childbearing potential must have a negative serum pregnancy test within 48 hours of transplant and agree to use reliable contraception with two contraceptive methods for a minimum of 2 years following abdominal wall transplantation. Subjects seeking to become pregnant following 2 years will be made aware during the consent process that the effect of pregnancy on the transplanted abdominal wall and vice versa is unknown. * Medical exclusion criteria for general anesthesia * Ongoing substance abuse or history of untreated substance abuse
Contact & Investigator
Linda Cendales, MD
PRINCIPAL INVESTIGATOR
Duke University
Frequently Asked Questions
Who can join the NCT03310905 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Transplant;Failure,Kidney. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03310905 currently recruiting?
Yes, NCT03310905 is actively recruiting participants. Contact the research team at linda.cendales@duke.edu for enrollment information.
Where is the NCT03310905 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT03310905 clinical trial?
NCT03310905 is sponsored by Duke University. The principal investigator is Linda Cendales, MD at Duke University. The trial plans to enroll 5 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.